If the lots were distributed evenly to every place doing injections then poor administration should be evenly distributed across batches, but that's not how it works.
Vaccines are purchased in bulk, so a whole batch or most of a batch might go to a specific customer.
Dr. John Campbell estimates that as many as 1 in 6000 or so injections are administered into a blood vessel so this should have a big effect on outcomes.
Or their ability to produce a consistent product is shit. The same batches went to different states and were still high on the adverse events reported.
Is this because some nurses are injecting it incorrectly into the blood vessel?
Probably not, that's covered later in the article, you'd except a more normal distribution.
If the lots were distributed evenly to every place doing injections then poor administration should be evenly distributed across batches, but that's not how it works.
Vaccines are purchased in bulk, so a whole batch or most of a batch might go to a specific customer.
Dr. John Campbell estimates that as many as 1 in 6000 or so injections are administered into a blood vessel so this should have a big effect on outcomes.
Or their ability to produce a consistent product is shit. The same batches went to different states and were still high on the adverse events reported.